RDW (Red Cell Distribution Width)
RDW quantifies the variation in size among red blood cells in a sample. Elevated RDW suggests a mixed population, often from iron, B12, or folate deficiency, recent blood loss, or marrow recovery. Higher RDW is also linked with cardiovascular events and all-cause mortality independent of anemia status.
Units: %. Check the units on your report before comparing to any range here.
Optimal range: who says what
Institutions, researchers and practitioners draw the line in different places. Each position is listed with who holds it and, where a document states it, a link. How we verify ranges.
- Institution or study<12.6% (lowest-risk quintile)NHANES III (Patel et al. 2009, Arch Intern Med)Each 1% higher RDW went with 22% higher all-cause mortality; the association held in people without anemia and within the 11-15% reference range
- Institution or studyLower is better; no thresholdNHANES III (Perlstein et al. 2009, Arch Intern Med)Each 0.98% (one standard deviation) higher RDW went with 23% higher all-cause mortality in 15,852 adults
- Institution or studyLower is better; no thresholdMeta-analysis of seven community cohorts of older adults (Patel et al. 2010, J Gerontol)Total mortality rose 14% per 1% higher RDW in 11,827 older adults, and 32% per 1% in those without major age-related disease; study medians ran 13.2-14.6%
- Lab reference interval11.5-14.5%What a lab report flags against. A lab interval is not an optimal target.
20 of 21 itemized panels
Complete Blood Count (CBC)
What is RDW (Red Cell Distribution Width)?
RDW (Red Cell Distribution Width) measures the variation in red blood cell size. It is expressed as a percentage, with normal range 11.5-14.5%. Higher RDW means greater variation (anisocytosis)—some RBCs are much larger or smaller than others. Low RDW means uniform RBC size (all similar). RDW is calculated from the standard deviation of RBC volume divided by MCV.
RDW helps differentiate causes of anemia and has emerged as an independent predictor of mortality and cardiovascular disease. In iron deficiency anemia, RDW is typically high (>15%) as the bone marrow produces increasingly smaller RBCs as iron becomes scarce. In thalassemia trait, RDW is often normal despite low MCV because all RBCs are uniformly small. In B12/folate deficiency, RDW is high as large macrocytes and smaller cells coexist.
Beyond anemia, elevated RDW (>15%) independently predicts all-cause mortality, cardiovascular events, and poor outcomes in heart failure, sepsis, and many chronic diseases. The mechanism is unclear but may reflect chronic inflammation, oxidative stress, poor nutritional status, or ineffective erythropoiesis. RDW is increasingly recognized as a general health marker, not just an anemia parameter.
Why RDW Differentiates Anemias and Predicts Health Outcomes
- Iron deficiency vs thalassemia: High RDW + low MCV = iron deficiency. Normal RDW + low MCV = thalassemia trait. Distinguishes these common causes without expensive testing
- Anemia classification: Helps categorize anemias beyond MCV alone. Combined with MCV creates diagnostic matrix
- Mortality predictor: RDW >15% independently predicts 1.5-2x higher all-cause mortality in multiple populations, even without anemia
- Heart failure prognosis: Elevated RDW predicts worse outcomes in heart failure, independent of other biomarkers like BNP
- Early nutritional deficiency: RDW rises before anemia develops in iron, B12, or folate deficiency, allowing earlier intervention
- Inflammation marker: Chronic inflammation increases RDW, reflecting oxidative stress and ineffective erythropoiesis
Interpretation bands (curated, PMID-backed)
Holder: OptimizeBiomarkers editorial synthesis of: The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis (Su et al., 2014); Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis (Abrahan LL et al., 2018); The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population (Pan et al., 2019). No single paper sets these cutoffs; for attributed targets see who says what.
Optimal11.5-13.0%▼
- Uniform RBC size indicating healthy, efficient erythropoiesis
- Associated with lowest mortality risk and optimal health outcomes
- Reflects adequate iron, B12, folate stores and absence of chronic inflammation
Borderline High13.0-14.5%▼
- Upper normal range
- May indicate subclinical nutritional deficiency, mild inflammation, or early bone marrow dysfunction
- Check ferritin, B12, folate, CRP
- If anemia present, investigate aggressively
- Monitor every 6-12 months
Elevated14.5-17.0%▼
- High RBC size variation
- Common causes: iron deficiency (high RDW + low MCV), B12/folate deficiency (high RDW + high MCV), mixed deficiencies, hemolytic anemia, recent blood transfusion
- Check complete iron studies, B12, folate, reticulocyte count
- Associated with increased cardiovascular and mortality risk
Severely Elevated>17.0%▼
- Marked anisocytosis indicating significant pathology
- Causes: severe nutritional deficiency, myelodysplastic syndrome, hemolytic anemia, bone marrow disorders
- Requires comprehensive workup including peripheral smear, reticulocyte count, iron studies, B12, folate, possibly bone marrow biopsy
- Very high RDW (>20%) strongly predicts adverse outcomes
- The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis.
- Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis.
- The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population.
What raises or lowers RDW
Causes of high RDW
High RDW (>14.5%) causes:
- Nutritional deficiencies: Iron deficiency (most common), B12 deficiency, folate deficiency, copper deficiency, combined deficiencies
- Hemolytic anemia: Autoimmune hemolytic anemia, G6PD deficiency, hereditary spherocytosis, sickle cell disease
- Bone marrow disorders: Myelodysplastic syndrome, myelofibrosis, myelophthisic anemia (marrow infiltration)
- Chronic diseases: Heart failure, chronic kidney disease, liver disease, cancer, diabetes
- Inflammation: Rheumatoid arthritis, inflammatory bowel disease, chronic infections, sepsis
- Recent blood transfusion: Mixed donor and native RBC populations
- Medications: Chemotherapy, zidovudine, anticonvulsants causing macrocytosis
- Oxidative stress: Smoking, aging, chronic alcohol use
Causes of low RDW
Low RDW (<11.5%) is very rare and not clinically significant:
- May occur in chronic disease with uniform small cells
- Some forms of thalassemia trait
- Generally benign finding
Symptoms when RDW is high or low
When high
No symptoms directly from high RDW:
- If anemia present: Fatigue, dyspnea, pale skin
- If nutritional deficiency: Specific symptoms (pica for iron, neuropathy for B12)
- If chronic disease: Symptoms of underlying condition (heart failure, kidney disease, inflammation)
Clinical manifestations are from associated anemia or underlying disease, not from RDW elevation itself. High RDW is a red flag for investigation.
When low
RDW abnormalities cause no direct symptoms. Symptoms relate to underlying causes:
- High RDW with iron deficiency: Fatigue, ice craving, restless legs
- High RDW with B12 deficiency: Neuropathy, glossitis, cognitive changes
- High RDW with hemolysis: Jaundice, dark urine, back pain
- High RDW with chronic disease: Symptoms of underlying condition
RDW is a laboratory finding, not a clinical symptom. Its significance is in guiding diagnosis and prognosis.
How to move RDW
Effect sizes (how much something moves the marker) appear only where the paper cited under the item states them. Talk to your clinician before starting or changing any medication or supplement.
Treat Nutritional Deficiencies
- Iron deficiency (high RDW + low MCV): Ferrous sulfate 325 mg 2-3x daily. RDW normalizes in 3-4 months as uniformly normal RBCs replace deficient cells
- B12 deficiency (high RDW + high MCV): B12 1000 mcg IM weekly, then monthly. RDW decreases as new normal-sized RBCs are produced
- Folate deficiency: Folic acid 1-5 mg daily. RDW improves within 8-12 weeks
- Mixed deficiencies: Common in elderly or malnourished. Treat all deficiencies simultaneously. RDW may take 3-6 months to normalize
Reduce Inflammation and Oxidative Stress
- Anti-inflammatory diet: Mediterranean diet, omega-3 fatty acids (2-4g EPA+DHA daily) reduce oxidative stress affecting RBCs
- Treat chronic conditions: Rheumatoid arthritis, inflammatory bowel disease, chronic infections increase RDW through inflammation
- Antioxidants: Vitamin C (500-1000 mg), vitamin E (400 IU), selenium (200 mcg) may reduce RBC oxidative damage
- Exercise: Moderate regular exercise reduces inflammation. Avoid overtraining which increases oxidative stress
- Smoking cessation: Smoking dramatically increases RDW through oxidative damage and chronic inflammation
Manage Heart Failure and Cardiovascular Disease
- If high RDW with heart failure: Optimize medical therapy (ACE inhibitors, beta-blockers, diuretics). Elevated RDW predicts worse outcomes—may need more aggressive treatment
- Correct anemia if present: Even mild anemia worsens heart failure. Treat iron deficiency, consider ESAs if severe
- Monitor closely: RDW rising over time in heart failure predicts decompensation. Check every 3-6 months
- Address comorbidities: Kidney disease, diabetes, COPD often coexist with heart failure and increase RDW
Investigate Hemolysis or Bone Marrow Disorders
- If RDW >17% with reticulocytosis: Suggests hemolysis or recent bleeding. Check LDH, haptoglobin, indirect bilirubin, Coombs test
- Myelodysplastic syndrome: High RDW with unexplained cytopenias and macrocytosis. Requires bone marrow biopsy for diagnosis
- Mixed population: Recent blood transfusion creates two RBC populations (donor + native), elevating RDW. Normalizes over 3-4 months
- Bone marrow biopsy: If RDW >18% with unclear cause, consider bone marrow evaluation to exclude clonal disorders
Use RDW for Risk Stratification
- Cardiovascular risk: RDW >15% identifies high-risk patients requiring aggressive risk factor management
- Sepsis prognosis: RDW >15% on admission predicts higher mortality. May warrant ICU admission and closer monitoring
- Pre-operative risk: Elevated RDW predicts post-surgical complications. Optimize nutritional status before elective surgery
- Chronic disease monitoring: Rising RDW trend indicates disease progression or emerging complications. Investigate promptly
- General health marker: Even without specific disease, RDW >14.5% suggests need for comprehensive health assessment
When to retest
- If borderline high (13.5-14.5%) without anemia: Recheck in 6-12 months with ferritin, B12, folate, CRP. Monitor trend—rising RDW warrants investigation
- If high (>14.5%) with anemia: Retest every 4-8 weeks during treatment. RDW should decrease as new normal RBCs replace abnormal ones
- After treating nutritional deficiency: RDW normalizes slowly over 3-4 months (RBC lifespan). Don't expect rapid change
- In heart failure: Check RDW every 3-6 months. Rising RDW predicts decompensation and mortality
- If very high (>18%): Urgent workup with peripheral smear, reticulocyte count, comprehensive metabolic panel. Consider hematology referral
- General health monitoring: Annual RDW with CBC provides long-term trend. Progressive increase over years indicates emerging health issues
Scientific Evidence
RDW in Iron Deficiency vs Thalassemia
Classifying anemias by both MCV and red cell distribution width improves the distinction of iron deficiency from heterozygous thalassemia and anemia of chronic disease, and helps detect early iron and folate deficiency.
RDW and All-Cause Mortality
In 11,827 older adults from 7 community studies, each 1% increase in RDW raised total mortality risk by 14%, with similar associations for cardiovascular and cancer deaths. The association held in adults without major age-related disease.
Source: Red cell distribution width and mortality in older adults: a meta-analysis.
RDW in Heart Failure Prognosis
Among 36 routine lab values in 2,679 chronic heart failure patients (CHARM), higher RDW had the strongest association with illness and death (HR 1.17 per standard deviation). The finding replicated in 2,140 Duke Databank patients (HR 1.29 per standard deviation for death).
Which Providers Test RDW (Red Cell Distribution Width)?
Cheapest: Oura Health Panels at $99/year. Most comprehensive: Function Health, 160+ biomarkers for $365/year.
20 panels that include it, cheapest first
| Provider | Annual Cost | Total Biomarkers | $/Biomarker |
|---|---|---|---|
| $99 | 50 | $1.98 | |
| $190 | 100+ | $1.90 | |
| $250 | 65 | $3.85 | |
| $297 | 100+ | $2.97 | |
 Labcorp OnDemand | $338 | 50+ | $6.76 |
 Superpower | $349 | 100+ | $3.49 |
| $349 | 75+ | $4.65 | |
 WHOOP Advanced Labs | $349 | 65 | $5.37 |
 Function Health | $365 | 160+ | $2.28 |
| $365 | 100+ | $3.65 | |
| $375 | 108 | $3.47 | |
| $449 | 83 | $5.41 | |
| $495 | 80+ | $6.19 | |
| $499 | 100+ | $4.99 | |
| $700 | 138 | $5.07 | |
| $829 | 54 | $15.35 | |
| $895 | 100+ | $8.95 | |
| $1188 | 70+ | $16.97 | |
| $1198 | 40+ | $29.95 | |
| $1950 | 130+ | $15.00 |
$/Biomarker is annual cost divided by the panel's advertised biomarker count, not the price of this one test. We track 23 blood test providers (32 plans); 21 of those plans are itemized marker by marker. Compare all of them.
1 itemized panel does not include RDW (Red Cell Distribution Width)
11 providers not itemized in our matrix
We have not itemized these marker by marker (some sell tests one at a time), so this page cannot say whether they offer RDW (Red Cell Distribution Width). Check with them directly.
Life Extension Standard · Quest Health · Ultrahuman Blood Vision · Lifeforce · Hundred Health · Personalabs · Walk-In Lab · HealthLabs · WHOOP Specialized Panels · Marek Health Essential · Vitality Blueprint Upload
Frequently Asked Questions
What is the optimal range for RDW (Red Cell Distribution Width)?
Published positions differ: <12.6% (lowest-risk quintile) (NHANES III (Patel et al. 2009, Arch Intern Med)); Lower is better; no threshold (NHANES III (Perlstein et al. 2009, Arch Intern Med)); Lower is better; no threshold (Meta-analysis of seven community cohorts of older adults (Patel et al. 2010, J Gerontol)). Lab reference interval: 11.5-14.5%. That is what a lab report flags against, not an optimal target.
Which blood test providers include RDW (Red Cell Distribution Width)?
20 of the 21 blood testing panels we itemize marker by marker include RDW (Red Cell Distribution Width) in their panels. This biomarker is widely available across major providers.
Medical Disclaimer
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.
Last reviewed Sep 23, 2026 · First published Sep 30, 2025